Sell GSK Consumer; target of Rs 4380: Motilal Oswal

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Motilal Oswal's research report on GSK Consumer

Net sales (including operating income) grew 2.3% YoY (our estimate: 1.3% YoY decline) to INR 11b. EBITDA grew 1.5% YoY (our estimate: 3.5% decline) to INR 2.17b, while adjusted PAT grew 8.4% YoY (our estimate: 1.8% decline) to INR 1.76b. MFD volumes declined 1% YoY (our estimate: 5% decline).

Outlook

EPS CAGR over FY17-19 is likely to be muted at 9%. We do not think the core business deserves to trade at over 26x. Since outlook might worsen if market share declines persist, we downgrade the stock to SELL. Our target price of INR 4,380 (26x FY19E core EPS + cash) implies 17% downside.

For all recommendations, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More